COVID-19 | Research Continuity

Given disruptions in business as usual at many institutions, the American Epilepsy Society is deeply concerned about the effects of COVID-19 on epilepsy research that is in progress or planned. As information becomes available to support and guide those who are conducting basic, translational, and clinical research, AES will post it here.

AES Funding

• Whenever feasible, AES will offer flexibility on grant timelines and expectations
• AES-funded investigators: Contact grants@aesnet.org with any questions about your grant

Guidance on Clinical Trials

• FDA guidance on conducting clinical trials of medical products during COVID-19 pandemic
• Guidance for NIH-funded clinical trials and human subject studies affected by COVID-19

NIH Funding and Investigator Resources

• NIH Information for Applicants and Recipients of NIH Funding: This regularly updated page includes resources and information such as new and updated FAQs on grant programs, funding opportunities specific to COVID-19, and ... 
• NIH FAQ: What happens if an institution has already submitted an application, and some information must be revised due to the effects of COVID-19? 
• New NIH Resource to Analyze COVID-19 Literature: the COVID-19 Portfolio Tool 

COVID-19 Research Related to Epilepsy

GO FAIR has launched the Virus Outbreak Data Network to facilitate the creation and sharing of FAIR (Findable-Accessible-Interoperable-Reusable) data about COVID-19